City
Epaper

Bharat Biotech terms Rs 35K cr for Covid vaccine 'far-reaching'

By IANS | Updated: February 1, 2021 17:16 IST

Hyderabad, Feb 1 Covid-19 vaccine maker Bharat Biotech on Monday welcomed allocation of Rs 35,000 crore for Covid ...

Open in App

Hyderabad, Feb 1 Covid-19 vaccine maker Bharat Biotech on Monday welcomed allocation of Rs 35,000 crore for Covid vaccination in Union Budget 2021-22, terming it a "great" and "far-reaching step".

"The Finance Minister's commitment providing more funds in order to contain the coronavirus pandemic spread in the country and provide an effective, smooth path for the vaccination scheme will help contain, and lead our nation towards accomplishing a Covid-19 disease free Bharat," said Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech.

The Hyderabad-based vaccine maker has developed Covaxin, India's first indigenous Covid vaccine which is being administered in clinical trial mode as part of the ongoing nation-wide vaccination programme.

Ella, in a statement, said that the layout plan of a Rs 64,180 crore spending plan for healthcare over the next six years to be spent on primary, secondary and tertiary healthcare, in addition to the National Health Mission, is also a welcome move, which will strengthen public health services as 17,000 rural and 11,000 urban health and wellness centres and integrated public health labs are to be set up in each district.

"The government focus, on three areas - preventive health, curative health and well-being, is also very reassuring," he added.

Suchitra Ella, Joint Managing Director, Bharat Biotech stated that the new health infra schemes with significantly higher outlay of Rs 35,000 crore for Bharat's mega Covid vaccination drive is a huge fiscal medicine to contain the pandemic, reduce disease burden for the population, and the economy.

"A record total outlay of Rs 2,23,846 crore for health and wellbeing aimed to boost the health and well-being of the nation, is also a well-thought announcement in this budget, with focus on preventive, and curative health. It's encouraging to note the creation of 9 Bio Safety Labs (BSL) will boost research and scientific discoveries," she said.

Pharma major Dr Reddy's termed the Budget a growth-oriented with a lot of positive interventions, and with something in it for everyone.

"On healthcare, the Government has taken a big step with an outlay of 2.23 lakh crores, a 137 per cent increase from last year, a step that was long overdue. On innovation and R&D, the additional allocation of 50,000 crore over five years through the National Research Foundation marks a good beginning in improving the research eco-system in the country," said Satish Reddy, Chairman, Dr. Reddy's Laboratories Ltd.

"As with all budgets, there are concrete proposals that are encouraging but it is the execution that finally matters and I hope this time the government gets it right," he added.

( With inputs from IANS )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: FebruaryBharat biotechindiaHyderabadSatish ReddyNagarHyderIndiUk-indiaRepublic of indiaBharat biotech limited
Open in App

Related Stories

NationalMahaa News Office Attack in Hyderabad: BRS Cadres Pelt Stones at News Headquarters Building in Jubilee Hills

NationalHyderabad Shocker: Married Couple Arrested for Live-Streaming Their Sex Acts for Money

Maharashtra"This is Betrayal": Former MP Calls Out Prada for Allegedly Copying Kolhapuri Chappal Design

InternationalWhen Will Russia Deliver More S-400 Missiles to India? Major Update Revealed - Here’s Why It Was Delayed

MaharashtraSolapur Tragedy: Three Men Die on Spot After Speeding Dumper Rams Two-Wheeler

Business Realted Stories

BusinessGautam Adani meets Odisha CM to boost industrial development, port infrastructure

BusinessPiyush Goyal outlines top highlights of Commerce and Industry in last 10 days

BusinessRavi Agrawal re-appointed CBDT Chairman

BusinessIndia’s social security coverage leaps from 19 pc to 64.3 pc of population in last 10 years

BusinessGovt extends CBDT chairman Ravi Agrawal’s tenure by a year